Dynamics of tumor hypoxia measured with bioreductive hypoxic cell markers

被引:127
作者
Ljungkvist, Anna S. E. [1 ]
Bussink, Johan [1 ]
Kaanders, Johannes H. A. M. [1 ]
van der Kogel, Albert J. [1 ]
机构
[1] Radboud Univ Nijmegen, Ctr Med, Dept Radiat Oncol 874, NL-6500 HB Nijmegen, Netherlands
关键词
D O I
10.1667/RR0719.1
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Hypoxic cells are common in tumors and contribute to malignant progression, distant metastasis and resistance to radiotherapy. It is well known that tumors are heterogeneous with respect to the levels and duration of hypoxia. Several strategies, including high-oxygen-content gas breathing, radiosensitizers and hypoxic cytotoxins, have been developed to overcome hypoxia-mediated radioresistance. However, with these strategies, an increased tumor control rate is often accompanied by more severe side effects. Consequently, development of assays for prediction of tumor response and early monitoring of treatment responses could reduce both over- and undertreatment, thereby avoiding unnecessary side effects. The purpose of this review is to discuss different assays for measurement of hypoxia that can be used to detect changes in oxygen tension. The main focus is on exogenous bioreductive hypoxia markers (2-nitroimidazoles) such as pimonidazole, CCI-103F, EF5 and F-misonidazole. These are specifically reduced and bind to macromolecules in viable hypoxic cells. A number of these bioreductive drugs are approved for clinical use and can be detected with methods ranging from noninvasive PET imaging (low resolution) to microscopic imaging of tumor sections (high resolution). If the latter are stained for multiple markers, hypoxia can be analyzed in relation to different microenvironmental parameters such as vasculature, proliferation and endogenous hypoxia-related markers, for instance HIF1 alpha and CA-IX. In addition, temporal and spatial changes in hypoxia can be analyzed by consecutive injection of two different hypoxia markers. Therefore, bioreductive exogenous hypoxia markers are promising as tools for development of predictive assays or as tools for early treatment monitoring and validation of potential endogenous hypoxia markers. (c) 2007 by Radiation Research Society.
引用
收藏
页码:127 / 145
页数:19
相关论文
共 221 条
[31]   ACUTE-HYPOXIA IN TUMORS - IMPLICATIONS FOR MODIFIERS OF RADIATION EFFECTS [J].
CHAPLIN, DJ ;
DURAND, RE ;
OLIVE, PL .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1986, 12 (08) :1279-1282
[32]   A MARKER FOR HYPOXIC CELLS IN TUMORS WITH POTENTIAL CLINICAL APPLICABILITY [J].
CHAPMAN, JD ;
FRANKO, AJ ;
SHARPLIN, J .
BRITISH JOURNAL OF CANCER, 1981, 43 (04) :546-550
[33]   Measuring hypoxia and predicting tumor radioresistance with nuclear medicine assays [J].
Chapman, JD ;
Engelhardt, EL ;
Stobbe, CC ;
Schneider, RF ;
Gerald, GE .
RADIOTHERAPY AND ONCOLOGY, 1998, 46 (03) :229-237
[34]  
CHAPMAN JD, 1983, CANCER RES, V43, P1523
[35]   Identification of hypoxia-regulated proteins in head and neck cancer by proteomic and tissue array profiling [J].
Chen, YJ ;
Shi, GY ;
Wei, X ;
Kong, C ;
Zhao, SC ;
Gaw, AF ;
Chen, EY ;
Yang, GP ;
Giaccia, AJ ;
Le, QT ;
Koong, AC .
CANCER RESEARCH, 2004, 64 (20) :7302-7310
[36]   Evidence that involucrin, a marker for differentiation, is oxygen regulated in human squamous cell carcinomas [J].
Chou, SC ;
Azuma, Y ;
Varia, MA ;
Raleigh, JA .
BRITISH JOURNAL OF CANCER, 2004, 90 (03) :728-735
[37]   IMMUNOHISTOCHEMICAL DETECTION OF A HYPOXIA MARKER IN SPONTANEOUS CANINE TUMORS [J].
CLINE, JM ;
THRALL, DE ;
PAGE, RL ;
FRANKO, AJ ;
RALEIGH, JA .
BRITISH JOURNAL OF CANCER, 1990, 62 (06) :925-931
[38]   DISTRIBUTION OF THE HYPOXIA MARKER CCI-103F IN CANINE TUMORS [J].
CLINE, JM ;
THRALL, DE ;
ROSNER, GL ;
RALEIGH, JA .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1994, 28 (04) :921-933
[39]   DISTRIBUTION OF PIMONIDAZOLE AND RSU-1069 IN TUMOR AND NORMAL-TISSUES [J].
COBB, LM ;
NOLAN, J ;
BUTLER, SA .
BRITISH JOURNAL OF CANCER, 1990, 62 (06) :915-918
[40]   Measurement of tumor oxygenation: A comparison between polarographic needle electrodes and a time-resolved luminescence-based optical sensor [J].
Collingridge, DR ;
Young, WK ;
Vojnovic, B ;
Wardman, P ;
Lynch, EM ;
Hill, SA ;
Chaplin, DJ .
RADIATION RESEARCH, 1997, 147 (03) :329-334